Pharmacons ApS: Financial statements 2022
CVR: 36892870
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
Pharmacons ApS (CVR 36892870) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -11,425 and a net result of DKK -9,122 compared with DKK -31,535 the year before. Equity in the 2022 report amounted to DKK 143,250. The solvency ratio was 86.2%.
- Gross Profit
- DKK -11,425
- Profit/Loss
- DKK -9,122
- Equity
- DKK 143,250
- Total Assets
- DKK 166,251
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -11 t. | -9 t. | 143 t. | - |
| 2021 | - | -40 t. | -32 t. | 152 t. | - |
| 2020 | - | 22 t. | 20 t. | 184 t. | - |
| 2019 | - | 83 t. | 44 t. | 164 t. | 1 |
| 2018 | - | 4 t. | -120 t. | 120 t. | 1 |
Official annual report
Keep an eye on Pharmacons ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Pharmacons ApS
Pharmacons ApS was a Danish company of the type Anpartsselskab based in Helsingør, founded in 2015. The company has been dissolved on 26 May 2025. The company was registered under the industry Anden teknisk rådgivning. The company has 0 employees (2018). In 2024, the company reported a gross profit of DKK -17,821 and a net result of DKK -18,480 compared with DKK -61,739 the year before. Equity in the 2024 report amounted to DKK 63,032.